Want to join the conversation?
Emerging Markets revenue for $NKE was up 19% in 1Q16, driven by improvement in Mexico while 1Q16 demand creation was down 7%. $NKE expects inventories in North America to be elevated for 2Q16 and 3Q16 and anticipates an impact on GM in the near term while clearing excess inventory. EBIT was up 20%, driven by GM expansion and SG&A leverage.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.